Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 06 Mar 2025 – 20 Aug 2026, limited by DSP Nifty Private Bank Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Nifty Private Bank Index Fund | Nifty Bank |
|---|---|---|
| 06 Mar 2025 | ₹100.00 | ₹100.00 |
| 19 Apr 2025 | ₹111.47 | ₹111.64 |
| 03 Jun 2025 | ₹112.20 | ₹114.34 |
| 17 Jul 2025 | ₹114.87 | ₹116.87 |
| 30 Aug 2025 | ₹107.41 | ₹110.34 |
| 14 Oct 2025 | ₹114.00 | ₹116.18 |
| 27 Nov 2025 | ₹118.45 | ₹122.85 |
| 10 Jan 2026 | ₹117.17 | ₹121.85 |
| 24 Feb 2026 | ₹112.62 | ₹125.54 |
| 09 Apr 2026 | ₹102.35 | ₹112.74 |
| 23 May 2026 | ₹102.74 | ₹111.16 |
| 07 Jul 2026 | ₹110.51 | ₹119.69 |
| 20 Aug 2026 | ₹107.45 | ₹118.24 |
| Metric | DSP · Direct · IDCW NAV ₹10.74 Very High risk ★☆☆☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| -3.22% | +5.06% | |
| — | +7.78% | |
| — | +8.94% | |
| — | +10.39% | |
| +5.05% | +7.54% | |
| -3.45% | — | |
| — | +8.12% | |
| — | +12.83% | |
| — | +11.97% | |
| Risk | ||
| 16.49% | 13.54% | |
| -0.59 | 0.16 | |
| -0.84 | 0.22 | |
| -20.77% | -15.77% | |
| Nifty Bank | — | |
| — | +0.53% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 98.0% | |
| 0.57% | 0.34% | |
| ₹74.04Cr | ₹191.88Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 36% | 38% | |
| Anil Ghelani | — | |
| 06 Mar 2025 | — | |
| 10 | — | |
| 99.9% | — | |
| 0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.